English Japanese Korean Thai Traditional Chinese 简体中文
Publish Books Publish Media Products My Store Self Publish
Gold Cart
  1. Home
  2. Magazines
  3. Finance
  4. Investing
  5. 《財訊》577期-癌症醫療大突破
自體細胞療法開放 50萬癌友保命福音

《財訊》577期-癌症醫療大突破

Publisher 財訊雙週刊 /財信雜誌社股份有限公司
Save Saved
Released
2019/03/21
Language
Traditional Chinese
File format
PDF (104MB), fit in large screen and Pubook
Pages
213
ID
154828
Provide Adobe DRM
Provide PDF
Offer DRM free license
No
All You Can Read Subscribe and view similar 2,920 titles
Series 財訊雙週刊
All Issues 財訊雙週刊Found 418 match

Buy products firstAnd download app to watch

Details
DRM
NT$119
Subscribe 52 Issues
NT$2280
Explanation
eBook
Standard NT$150
Get NT$18 off
查看適用禮券
Buy
Preview
Buy for others
自體細胞療法開放，除了造福50萬名癌症病友外，還有300萬名退化性關節炎、嚴重燒燙傷患者都將受益。

細胞療法不僅開啟醫療的新紀元，也將催生生技產業的新發展。而民眾面對這項醫療大變革，又該如何確保醫療權益呢？

股王大立光的主導股東林耀英家族，決定成立閉鎖公司作為家族控股與傳承的平台，這一決定將在台灣家族集團間掀起新風潮。
◎本期編輯推薦
》關鍵5問 一次看懂細胞治療
》辜公怡火速接棒 掀起台泥集團新質變
》專訪熱銷4000萬冊漫畫作者弘兼憲史 「不希望台灣變得和中國一樣」
》百萬阿宅大軍相挺 尚凡股價創新高
》多次婉拒副手 賴清德變身小英對手

Details

Released
2019/03/21
Language
Traditional Chinese
File format
PDF: Fit in large screen
Provide Adobe DRM
Provide PDF
Offer DRM free license
No
ID
154828

Buy products firstAnd download app to watch

Details
　　

Review

0 ratings
1 stars
0%
2 stars
0%
3 stars
0%
4 stars
0%
5 stars
0%
Write a review
Eligible to write reviews after purchasing products or add to Library